Objective: The euglycemic-hyperinsulinemic clamp is the gold standard to evaluate insulin resistance (IR), but there are only a few studies on the prevalence of IR in Chinese Han women with polycystic ovary syndrome (PCOS). This study investi- Measurements: Clamp-measured IS, age, BMI, and total testosterone.
| INTRODUC TI ON
Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disturbance in women of reproductive age. PCOS is characterized by hyperandrogenism and anovulatory infertility, and has substantial short-and long-term reproductive, psychological and metabolic implications. 1, 2 The prevalence of PCOS varies between 5% and 15% with ethnicity. 3 The mechanism is complex and remains unclear. 3 Insulin resistance (IR) is defined as reduced insulin sensitivity (IS) and refers to an increased amount of insulin needed to perform its metabolic actions. 4 IR occurs in 40%-70% of women with PCOS. [5] [6] [7] It is usually accepted that obese women with PCOS have IR. Obesity may increase PCOS prevalence and exacerbate IR in women with PCOS. 1, 8 Consensus is yet to be achieved in lean women with PCOS since IR is not consistently demonstrated. 9, 10 The euglycemic-hyperinsulinemic clamp is considered the gold standard to directly measure IS in research settings, but the complexity of the clamp technique has directed clinical researchers towards the use of fasting parameters of glucose homeostasis as surrogate measures of IR. 10 Usually, only small studies use the euglycemic-hyperinsulinemic clamp, 9, [11] [12] [13] while indirect methods such as the homeostatic model assessment (HOMA) are broadly used in large-scale metabolic studies on PCOS. [14] [15] [16] A systematic review and meta-analysis of euglycemichyperinsulinemic clamp studies showed that the inherent reduction in IS is 27% and body mass index (BMI) exacerbates the reduction in IS by 15% in women with PCOS. 17 Only a few studies on the prevalence of IR are reported in Chinese Han women with PCOS. Li et al 11 showed that IR was a common finding in women with PCOS and normal glucose tolerance and that BMI >25.545 kg/m 2 indicated impaired β-cell function in these women. 
| MATERIAL S AND ME THODS

| Participants
In 
| Data collection
All patients underwent anthropometric measurements: height, weight, waist circumference (WC) and hip circumference (HC). BMI was determined as the ratio between weight in kilograms and the square of height in metres. Waist-hip ratio (WHR) was determined as the ratio between WC and HC, in centimetres.
| Biochemical measurements
Fasting blood was sampled for the measurement of serum total testosterone levels, anytime between days 8 and 10 of the menstrual cycle or during amenorrhoea after excluding pregnancy. All blood samples were kept at −80°C. 
| Euglycemic-hyperinsulinemic clamp
Euglycemic-hyperinsulinemic clamps were performed in all subjects, as in our previous reports. 12 After fasting overnight, subjects were admitted to the hospital. Venous catheters were placed in both arms for insulin infusion, glucose infusion and blood sampling. The insulin infusion was performed with a 10-minutes priming dose of short-acting human insulin (Humulin, Lilly) and maintained at a rate of 120 mU/(m 2 × min) for 170 min.
A variable infusion of 20% glucose was started on the fourth minute to maintain the plasma glucose levels at 5. 
| Statistical analysis
All statistical analyses were performed using SPSS 13. was considered statistically significant.
| RE SULTS
| General characteristics
Compared with control subjects, the women with PCOS were younger and had higher BMI, WC, WHR, total testosterone, fasting plasma glucose and fasting serum insulin (all P < 0.05). As expected, compared with controls, women with PCOS had a lower M value (P < 0.001) and higher HOMA-IR (P = 0.001) ( Table 1 ). The M value averaged 12.47 mg/min/kg in control subjects and was 30.3% lower in women with PCOS.
| Subgroup analysis
According to BMI, the women with PCOS were divided into the lean (BMI <24 kg/m 2 ), overweight (BMI 24-28 kg/m 2 ), and obese (BMI ≥28 kg/m 2 ) subgroups. After excluding one control with obesity and three with overweight, 36 lean controls were included in the analyses. As expected, compared with the lean controls, women with PCOS had lower M value (P < 0.001) and higher HOMA-IR (P < 0.001; Figure 1 ). M value averaged 12.24 mg/min/kg in lean controls, lower by 18.8% in lean women with PCOS, by 42.5% in overweight women with PCOS, and by 56.7% in obese women with PCOS (P < 0.05, unmatched subjects) ( Table 2) . Similar results were observed in the matched analysis (Supporting Information Table S1 ). Table 2 shows that the prevalence of IR was lower when using HOMA-IR than when using the M value. The prevalence of IR estimated by the M value was 56.3% in women with PCOS, or 34.5%, 80.2% and 98.7% in lean, overweight, and obese women with PCOS, respectively (P < 0.05). The prevalence of IR estimated by HOMA-IR was 27.9% in women with PCOS, or15.6%, 41.6% and 58.6% in lean, overweight and obese women with PCOS, respectively (P < 0.05) ( Table 2) .
A logistic regression analysis showed that when using the M value and compared with lean women with PCOS, overweight and obese women with PCOS had higher risk of IR (overweight: 
TA B L E 1 General characteristics of PCOS women and control subjects
| Bivariate analysis
The Pearson correlation analysis showed that in all subjects, the M value correlated with BMI, WC, WHR and total testosterone (r = −0.64, r = −0.64, r = −0.54 and r = −0.13, respectively, P < 0.001, P < 0.001, P < 0.001 and P = 0.004, respectively), but not with age (P = 0.069). HOMA-IR correlated with BMI, WC and WHR (r = 0.50, r = 0.47 and r = 0.37, respectively, P < 0.001, P < 0.001 and P < 0.001),
but not with total testosterone (P = 0.162) and age (P = 0.825).
| Multivariate analysis
Two multiple linear regression analyses were performed with two models, respectively, including the M value and HOMA-IR as the dependent variables. The M value (R 2 = 0.48, P < 0.001) was independently associated with BMI (β = −0.52, P < 0.001), WHR (β = −0.23, P < 0.001), total testosterone (β = −0.07, P = 0.045), and age (β = 0.17, P < 0.001). After adjustment for WHR, total testosterone and age, HOMA-IR was only associated with BMI (R 2 = 0.25, β = 0.50, P < 0.001).
| PCOS subtypes
A subgroup analysis was performed among 337 patients with available PCOS subtype data. Table 3 shows that there were no differences in BMI groups distribution (P = 0.56), HOMA-IR (P = 0.95), and M value (P = 0.18) among the four PCOS subtypes.
| D ISCUSS I ON
In this cross-sectional study of IR determined by euglycemic-hy- F I G U R E 1 A, M value of the four groups of women. General P < 0.001; all P < 0.05 between each pair of groups. B, HOMA-IR of the four groups of women. General P < 0.001; *P < 0.05
As in ours and others' previous reports, [11] [12] [13] 24 the present study showed that women with PCOS have intrinsic reduction in IS on euglycemic-hyperinsulinemic clamp and almost all obese women with PCOS have more serious IR than lean women with PCOS. This relationship between BMI and IR in PCOS was also observed in Caucasians. 24 A systematic review and meta-analysis of euglycemic-hyperinsulinemic clamp studies by Cassar et al showed that the inherent reduction in IS is 27% and BMI exacerbates the reduction in IS by 15% in women with PCOS. 17 Therefore, weight loss should be very important to improve IS and attenuate the complications of PCOS. It is interesting that WHR is independently associated with IR after adjusting for BMI in the present study.
Therefore, the role of central obesity on PCOS-related IR should also draw our attention.
Same as in previous studies, [25] [26] [27] the present study showed that the average BMI in Chinese patients with PCOS was within the normal range (23.2 kg/m 2 ) and that up to 64.5% were lean.
On the contrary, most studies from Western countries showed that the average BMI of women with PCOS was usually >30 kg/ m 2 . 14, 24, 28, 29 Because the prevalence and degree of IR increase with BMI, 24 it can be speculated that low BMI may be the main cause for the lower prevalence and degree of IR in Chinese women with PCOS compared with their Western counterparts. In addition, the multiple linear regression analysis showed that increasing age adversely impacted IR, while high levels of total testosterone positively impacted it, but the impact of testosterone was trivial after adjustment for BMI and WHR. The different subtypes of PCOS were not associated with differences in HOMA-IR or M value. This is in contradiction to a previous study by Zhang et al 30 that showed that the patients with the OHP and OH subtypes had the highest IR, followed by the HP and then by the OP subtypes.
Xu et al 31 and Sobti et al 32 showed that patients with and without hyperandrogenism had different glucose metabolism parameters.
Fica et al 33 highlighted that patients with different PCOS subtypes respond differently to metformin. Further study is necessary to rule out these discrepancies.
The prevalence of IR in women with PCOS shows a marked variation among ethnic groups, being 83.6% in Arabs, 76% in Americans, 72% in Italians, 70% in Mexican-Americans, 75%
in British and 68% in Japanese. 15, 24, 34 In the present study, the A recent study in Caucasians also showed that the surrogate markers of IR resulted in a lower prevalence of IR compared with the M value. 24 These results suggest that the underestimated prevalence of IR by HOMA should be corrected in women with PCOS. Nevertheless, it must also be stressed that the HOMA-IR cut-off points cannot be generalized since they depend upon the insulin assay being used. Additional studies are necessary to examine this issue. our specific study population. Finally, the study was conducted on a selected group of patients with PCOS who were admitted to an endocrinology clinic and obstetrics and gynecology clinic.
Studying unselected patients with PCOS using a population-based survey might be the optimal way to determine the real prevalence of IR in this population.
In conclusion, 56.3% of Chinese Han women with PCOS had IR and their reduction in IS was 30.3%. IR was an intrinsic characteristic of Chinese women with PCOS and obesity exacerbated reduction in IS. When being evaluated by HOMA, the prevalence and the risk factors of IR in Chinese women with PCOS were underestimated.
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